Buy These 2 Biotech Stocks on the Dip After an FDA Delay

Buy These 2 Biotech Stocks on the Dip After an FDA DelayDon't worry about the FDA's clinical hold on gene-editing therapy CTX001. Vertex and CRISPR Therapeutics stocks will bounce back.




from Yahoo Finance https://ift.tt/2JrcvU2

Comments

Popular posts from this blog

What are the key measures of market volatility?